MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹10,233 Cr |
Mar2024 | ₹5.27 Cr |
Mar2023 | ₹-740 Cr |
Mar2022 | ₹605 Cr |
Mar2021 | ₹-7.81 Cr |
How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹10,233 Cr | 194,066.22 | |
Mar2024 | ₹5.27 Cr | Positive | |
Mar2023 | ₹-740 Cr | Negative | |
Mar2022 | ₹605 Cr | Positive | |
Mar2021 | ₹-7.81 Cr | - |
Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹100,597.3 Cr | -3.7% | -3.3% | -8.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,682.0 Cr | -2% | 2% | -16.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,985.0 Cr | -5% | -6.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,862.0 Cr | -0.4% | 0.5% | 5.2% | Stock Analytics | |
CIPLA | ₹121,294.0 Cr | -2.4% | -5.4% | -8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,132.0 Cr | -5.8% | -4.4% | -8.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -3.7% |
-3.3% |
-8.3% |
SENSEX | -2.2% |
0.6% |
-5.8% |
You may also like the below Video Courses